MedTrace Logo

"Examination of the Impact of a Dynamic Flexion Orthosis (Dynaflex®Ottobock) or of a Back Bandage (Lumbo Sensa®Ottobock) on the Voluntary Activation of the Back Muscles in Patients With Specific Back Pain"

NCT02536274 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-08-31

No results posted yet for this study

Summary

Aim of the study is to analyze systematically by using surface EMG the effect of the dynamic flexion orthosis Dynaflex® and the back bandage Lumbo Sensa® on the voluntary activation of the low back muscles and thereby on the muscles' stiffness.

Patients have to pass a course with 6 different exercises in which they have to carry out certain activities of daily life under controlled conditions to examine, if the particular technical aid has a positive impact on pain-related activation of the back muscles.

Conditions

Interventions

DEVICE

Lumbo Sensa® bandage

Patients have to wear it over 21-28 days for at least 8 hours a day

DEVICE

Dynaflex® flexion orthosis

Patients have to wear it over 21-28 days for at least 8 hours a day

Sponsors & Collaborators

  • Reha-Klinik Schwertbad

    collaborator UNKNOWN

  • Schön Klinik Nürnberg Fürth

    collaborator UNKNOWN

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Catherine Disselhorst-Klug, Univ.-Prof. Dr. rer. nat. · Head: Dept. of Rehabilitation and Prevention Engineering, Institute of Applied Medical Engineering RWTH Aachen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02536274 on ClinicalTrials.gov